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Alcohol and blood pressure
The systematic review and meta-analysis by 
Michael Roerecke and colleagues1 extends our knowledge 
of the association between alcohol and blood pressure 
by showing a dose-dependent association between 
baseline alcohol intake and the blood pressure-lowering 
eﬀ ect of a subsequent reduction in alcohol intake, 
with an apparent threshold at two standard drinks—ie, 
24 g pure alcohol per day. In other words, although no 
signiﬁ cant eﬀ ect of lowering alcohol consumption was 
recorded in individuals with a daily intake of two or fewer 
drinks, eﬀ ect sizes were greatest in those who had the 
highest intake beyond two drinks per day, irrespective 
of baseline cardiovascular risk. For example, in people 
who drank six or more drinks per day, a reduction in 
alcohol intake of about 50% was associated with mean 
reductions in systolic and diastolic blood pressure of 
5·50 mm Hg and 3·97 mm Hg, respectively, similar to the 
beneﬁ t of other lifestyle changes—eg, increased physical 
activity and weight loss.2
Three closely linked key questions require further 
clariﬁ cation: the mechanisms for the observed asso-
ciation; strategies for ensuring a sustained reduction 
in alcohol consumption and subsequently in blood 
pressure as median trial duration was limited to 
4 weeks; and the prognostic implications of blood 
pressure-lowering due to reduced alcohol consumption. 
In this regard, an inherent weakness of the study was 
the paucity of information about potentially related 
behavioural and lifestyle changes, including treatment 
compliance, stress coping, physical activity, diet, and 
weight.3 This is especially important because individuals 
capable of reducing their alcohol intake from 6–10 to 
3–5 drinks per day might represent a highly motivated 
group, who are willing to adopt additional healthy 
lifestyle changes. Furthermore, this mechanistic 
uncertainty obscures prognostication with respect 
to cardiovascular outcome. However, because several 
components of lifestyle modiﬁ cation have proven 
advantageous without adverse eﬀ ects,4,5 it is likely 
that a sustained reduction in alcohol consumption in 
people drinking more than two drinks per day will be 
accompanied by a reduction in both blood pressure and 
subsequent cardiovascular events.
Recent ﬁ ndings have brought into question the 
previous idea of a protective beneﬁ t of low-moderate 
alcohol intake (ie, 1–2 drinks per day).6,7 Whereas 
consumption of more than two drinks per day is 
associated with adverse outcomes, it remains unclear 
whether one to two drinks per day have protective, 
neutral, or harmful eﬀ ects. Therefore, contemporary 
guidelines for both hypertension2 and cardiovascular 
disease prevention8 recommend moderation of alcohol 
consumption, corresponding to approximate daily 
intakes of less than 20 g in men and less than 10 g in 
women. Although the results presented agree with 
the recommendations for men, data for women were 
scarce and should be interpreted cautiously. For this 
reason, it seems reasonable to continue with the 
current sex-speciﬁ c recommendations until further 
evidence is available.
Roerecke and colleagues should be commended for 
their important study, which shows that a reduction in 
alcohol consumption in people with a baseline intake 
of more than two drinks per day is associated with a 
signiﬁ cant blood pressure reduction that increases with 
higher baseline alcohol intake. This ﬁ nding is of great 
public health interest because both alcohol intake and 
raised blood pressure are important risk factors for the 
global burden of non-communicable diseases3 and, 
therefore, are targets for the WHO global action plan 
for the prevention and control of non-communicable 
diseases9 and the collaborative HEARTS10 initiative 
addressing healthy lifestyle, evidence-based protocols, 
access to essential medicines and technologies, 
risk-based management, team-based care and training, 
systems for monitoring and implementation module. 
Soon, HEARTS might help to answer the unanswered 
mechanistic questions through a combination of 
intervention and monitoring.
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